US Patent Issued to Merck Sharp & Dohme on April 21 for "Amido-substituted heterocyclic compounds and methods of use thereof for the treatment of herpes viruses" (American, British Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,369, issued on April 21, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.). "Amido-substituted heterocyclic compounds and methods of ... Read More

US Patent Issued to University of Cincinnati on April 21 for "Agents and compositions for the treatment of glioblastoma" (Ohio Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,370, issued on April 21, was assigned to University of Cincinnati (Cincinnati). "Agents and compositions for the treatment of glioblastoma... Read More

US Patent Issued to The Board of Trustees of the Leland Stanford Junior University, The United States Governmment as represented by the Department of Veterans Affairs on April 21 for "Combination therapy for cancer" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,371, issued on April 21, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.) and The United S... Read More

US Patent Issued to Celgene on April 21 for "Combination therapy for the treatment of cancer" (New Jersey Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,372, issued on April 21, was assigned to Celgene Corp. (Summit, N.J.). "Combination therapy for the treatment of cancer" was invented by M... Read More

US Patent Issued to Memorial Sloan Kettering Cancer Center, St. Jude Children's Research Hospital on April 21 for "Methods and compositions of inhibiting DCN1-UBC12 interaction" (Tennessee, New York, Arkansas Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,373, issued on April 21, was assigned to Memorial Sloan Kettering Cancer Center (New York) and St. Jude Children's Research Hospital Inc. (... Read More

US Patent Issued to The Brigham and Women's Hospital on April 21 for "Methods for drug screening and compositions useful for the inhibition of cell proliferation and/or cell survival" (Massachusetts Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,374, issued on April 21, was assigned to The Brigham and Women's Hospital Inc. (Boston). "Methods for drug screening and compositions usef... Read More

US Patent Issued to Shanghai Runshi Medical Technology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences on April 21 for "Use of CSF-1R kinase inhibitor" (Chinese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,375, issued on April 21, was assigned to Shanghai Runshi Medical Technology Co. Ltd (Shanghai) and Shanghai Institute of Materia Medica, Ch... Read More

US Patent Issued to Genentech, Hoffmann-La Roche on April 21 for "Methods of treating relapsing multiple sclerosis using an inhibitor of Bruton's tyrosine kinase" (Swiss, American Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,376, issued on April 21, was assigned to Genentech Inc. (South San Francisco, Calif.) and Hoffmann-La Roche Inc. (Little Falls, N.J.). "Me... Read More

US Patent Issued to Endeavor BioMedicines on April 21 for "Methods of treating fibrosis" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,377, issued on April 21, was assigned to Endeavor BioMedicines Inc. (San Diego). "Methods of treating fibrosis" was invented by Luis A Del... Read More

US Patent Issued on April 21 for "Small therapeutic molecules capable of inhibiting the catalytic activity of the main protease enzyme of SARS-CoV-2" (Turkish Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,378, issued on April 21. "Small therapeutic molecules capable of inhibiting the catalytic activity of the main protease enzyme of SARS-CoV... Read More

• ««
• «
• 40784
• 40785
• 40786
• 40787
• 40788
• 40789
• 40790
• 40791
• 40792
• 40793
• »
• »»